Primary |
Oral Contraception |
26.9% |
Menorrhagia |
23.1% |
Dysmenorrhoea |
15.4% |
Contraception |
11.5% |
Hiv Infection |
11.5% |
Hormone Replacement Therapy |
7.7% |
Convulsion |
3.8% |
|
Trigeminal Neuralgia |
23.1% |
Visual Acuity Reduced |
15.4% |
Anaemia |
7.7% |
Breast Cancer |
7.7% |
Cerebral Venous Thrombosis |
7.7% |
Menorrhagia |
7.7% |
Superior Sagittal Sinus Thrombosis |
7.7% |
Systemic Lupus Erythematosus |
7.7% |
Vaginal Haemorrhage |
7.7% |
Vasculitic Rash |
7.7% |
|
Secondary |
Menorrhagia |
19.7% |
Hiv Infection |
16.9% |
Dysmenorrhoea |
14.1% |
Anaemia |
8.5% |
Contraception |
7.0% |
Maternal Exposure During Pregnancy |
5.6% |
Migraine |
5.6% |
Oral Contraception |
5.6% |
Product Used For Unknown Indication |
4.2% |
Acne |
2.8% |
Hormone Replacement Therapy |
2.8% |
Psychotic Disorder |
2.8% |
Tooth Infection |
2.8% |
Schizophrenia |
1.4% |
|
Menorrhagia |
18.2% |
Pregnancy On Oral Contraceptive |
13.6% |
Cryptorchism |
9.1% |
Drug Interaction |
9.1% |
Abnormal Behaviour |
4.5% |
Affective Disorder |
4.5% |
Breast Cancer |
4.5% |
Cardiac Arrest |
4.5% |
Cerebral Infarction |
4.5% |
Cyanosis |
4.5% |
Dysmorphism |
4.5% |
Maternal Exposure During Pregnancy |
4.5% |
Respiratory Disorder |
4.5% |
Swollen Tongue |
4.5% |
Urinary Tract Infection |
4.5% |
|
Concomitant |
Product Used For Unknown Indication |
19.8% |
Contraception |
17.4% |
Rheumatoid Arthritis |
10.3% |
Drug Use For Unknown Indication |
7.9% |
Depression |
7.3% |
Epilepsy |
4.3% |
Asthma |
4.1% |
Hypertension |
2.7% |
Obesity |
2.7% |
Smoking Cessation Therapy |
2.7% |
Back Pain |
2.4% |
Hormone Replacement Therapy |
2.4% |
Colitis Ulcerative |
2.2% |
Dyspepsia |
2.2% |
Nasopharyngitis |
2.2% |
Dermatitis Atopic |
1.9% |
Infection |
1.9% |
Migraine |
1.9% |
Oral Contraception |
1.9% |
Crohn's Disease |
1.6% |
|
Maternal Drugs Affecting Foetus |
8.9% |
Nausea |
8.9% |
Drug Exposure During Pregnancy |
7.6% |
Self-injurious Ideation |
7.6% |
Suicidal Ideation |
6.3% |
Abortion Spontaneous |
5.1% |
Cerebral Haemorrhage |
5.1% |
Maternal Exposure During Pregnancy |
5.1% |
Pruritus |
5.1% |
Vomiting |
5.1% |
Cerebellar Syndrome |
3.8% |
Gastroenteritis |
3.8% |
Headache |
3.8% |
Hypospadias |
3.8% |
Pneumonia |
3.8% |
Restless Legs Syndrome |
3.8% |
Skin Ulcer |
3.8% |
Superior Sagittal Sinus Thrombosis |
3.8% |
Angioedema |
2.5% |
Arthralgia |
2.5% |
|
Interacting |
Contraception |
12.2% |
Depression |
9.8% |
Dysmenorrhoea |
9.8% |
Fatigue |
9.8% |
Insomnia |
9.8% |
Menorrhagia |
9.8% |
Osteopenia |
9.8% |
Raynaud's Phenomenon |
9.8% |
Hiv Infection |
4.9% |
Multiple Sclerosis |
4.9% |
Product Used For Unknown Indication |
4.9% |
Psoriasis |
4.9% |
|
Pregnancy On Oral Contraceptive |
20.0% |
Unintended Pregnancy |
20.0% |
Anaemia |
10.0% |
Arthralgia |
10.0% |
Drug Interaction |
10.0% |
Lupus-like Syndrome |
10.0% |
Rash |
10.0% |
Rash Erythematous |
10.0% |
|